EUVIMEDEUVIMED entdecken
Open Access

Cardiomyocyte‐Specific Smad7 Protects the Pressure‐Overloaded Heart, Inhibiting the Transforming Growth Factor‐β Receptor 1/Smad2/3 Cascade

Claudio Humeres, Izabela Tuleta iD, Dongze Qin iD, Arti V Shinde iD, Aadya Deepak, Anis Hanna iD, Nikolaos G Frangogiannis iD

Journal of the American Heart Association · 07.07.2026 · 15 (13)

DOI: 10.1161/jaha.125.045203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.07.2026. Verfasst von Claudio Humeres und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Department of Microbiology and Immunology Albert Einstein Col…. Hauptthemen laut MEDLINE: Smad7 Protein, Myocytes, Cardiac, Smad3 Protein, Smad2 Protein. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effects of TGF‐βs (transforming growth factor‐βs) in failing hearts involve cell‐specific actions mediated through receptor‐regulated Smads or Smad‐independent pathways. The inhibitory Smad, Smad7, is a negative feedback regulator that restrains excessive TGF‐β/receptor‐regulated Smad signaling, while also exerting TGF‐β–independent effects. We hypothesized that cardiomyocyte Smad7 upregulation contributes to the pathogenesis of pressure overload–induced heart failure and investigated the mechanisms underlying its actions.

Methods

Cardiomyocyte‐specific Smad7 knockout mice and corresponding Cre+ and Smad7 fl/fl controls underwent transverse aortic constriction. Echocardiographic, histological, transcriptomic, and proteomic analyses were performed. RNA sequencing identified candidate pathways modulated by Smad7. Effects of Smad7 loss on TGF‐β and ERBB2 (erb‐b2 receptor tyrosine kinase 2) cascades were examined in vivo and in cardiomyocyte‐like H9c2 cells using western blotting.

Results

Smad7 was upregulated in cardiomyocytes and fibroblasts following transverse aortic constriction and in patients with nonischemic cardiomyopathy. Cardiomyocyte‐specific Smad7 knockout mice had no baseline abnormalities but developed worse systolic and diastolic dysfunction and increased cardiomyocyte hypertrophy after pressure overload. Cardiomyocyte Smad7 loss did not alter fibrosis after transverse aortic constriction but increased macrophage infiltration. Cardiomyocyte‐specific Smad7 knockout hearts showed reduced expression of genes associated with cardiac contraction. Bioinformatic analysis identified TGF‐β1, angiotensin, and ERBB2 as candidate upstream regulators mediating the effects of Smad7 loss. In vivo, cardiomyocyte Smad7 inhibited activation of TGF‐β receptor 1 ( TGFBR1)/Smad2/3 and ERBB2 without affecting TGF‐β receptor 2 ( TGFBR2) activity. In the absence of Smad7, pressure‐overloaded cardiomyocytes exhibited increased TGFBR1/Smad3 activation. In H9c2 cells, endogenous Smad7 restrained TGFBR1/Smad3 activation without affecting TGFBR2 or ERBB2 activity.

Conclusions

Cardiomyocyte Smad7 protects the pressure‐overloaded heart from dysfunction, regulating genes involved in muscle contraction, likely through direct suppression of TGFBR1/Smad3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad7 ProteinMyocytes, CardiacSmad3 ProteinSmad2 ProteinHeart FailureReceptor, Transforming Growth Factor-beta Type IAnimalsMice, KnockoutSignal TransductionMiceDisease Models, AnimalMaleHumansRatsMice, Inbred C57BLVentricular Remodeling

Stichwörter der Autor:innen

ERBB2SmadTGF‐βcardiomyocyteheart failure

Substanzen

Smad7 ProteinSmad7 protein, mouseSmad3 ProteinSmad2 ProteinReceptor, Transforming Growth Factor-beta Type ISmad2 protein, mouseSmad3 protein, mouseTgfbr1 protein, mouse

Autor:innen und Institutionen

  • The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Department of Microbiology and Immunology Albert Einstein College of Medicine Bronx NY USA.

ORCID-Profile: Izabela Tuleta, Dongze Qin, Arti V Shinde, Anis Hanna, Nikolaos G Frangogiannis

Zitieren

APA

Humeres, C., Tuleta, I., Qin, D., Shinde, A. V., Deepak, A., Hanna, A., & Frangogiannis, N. G. (2026). Cardiomyocyte‐Specific Smad7 Protects the Pressure‐Overloaded Heart, Inhibiting the Transforming Growth Factor‐β Receptor 1/Smad2/3 Cascade. Journal of the American Heart Association, 15(13). https://doi.org/10.1161/jaha.125.045203

Vancouver

Humeres C, Tuleta I, Qin D, Shinde AV, Deepak A, Hanna A, et al. Cardiomyocyte‐Specific Smad7 Protects the Pressure‐Overloaded Heart, Inhibiting the Transforming Growth Factor‐β Receptor 1/Smad2/3 Cascade. Journal of the American Heart Association. 2026;15(13). doi:10.1161/jaha.125.045203

BibTeX
@article{Humeres2026,
  author = {Humeres, Claudio and Tuleta, Izabela and Qin, Dongze and Shinde, Arti V and Deepak, Aadya and Hanna, Anis and Frangogiannis, Nikolaos G},
  title = {Cardiomyocyte‐Specific Smad7 Protects the Pressure‐Overloaded Heart, Inhibiting the Transforming Growth Factor‐β Receptor 1/Smad2/3 Cascade},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {13},
  doi = {10.1161/jaha.125.045203}
}
Kostenlos starten →